Scientists invent new drug candidates to treat antibiotic-resistant bacteria

UC Irvine researchers have developed a new antibiotic that targets two parts of bacterial molecules, potentially ending the arms race against antibiotic-resistant infections. This modified version of vancomycin could prevent bacteria from evolving defenses, addressing a crisis that causes 35,000 deaths and 2.8 million illnesses annually in the U.S.